VASCULAR PERMEABILITY-INCREASING ACTIVITY POSSESSED BY TREPONEMA-PHAGEDENIS (REITER STRAIN)

被引：0

作者：

SUGAHARA, T

YAMAYA, S

TAKAHASHI, T

机构：

[1] HOSHI COLL PHARM,SHINAGAWA KU,TOKYO 142,JAPAN

[2] NIH,DEPT APPL IMMUNOL,SHINAGAWA KU,BETHESDA,MD 20205

来源：

CURRENT MICROBIOLOGY | 1985年 / 12卷 / 02期

关键词：

D O I：

10.1007/BF01567402

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

下载

页码：113 / 116

页数：4

共 50 条

[41] The hypothetical protein P47 of Clostridium botulinum E1 strain Beluga has a structural topology similar to bactericidal/permeability-increasing protein
Lam, Kwok-ho
Qi, Ruifeng
Liu, Shun
Kroh, Amelie
Yao, Guorui
Perry, Kay
Rummel, Andreas
Jin, Rongsheng
TOXICON, 2018, 147 : 19 - 26
[42] Capillary permeability-increasing enzyme-2 from the venom of Agkistrodon caliginosus (Kankoku-Mamushi): Activity resulting from the release of peptides from fibrinogen
Shimokawa, KI
Takahashi, H
TOXICON, 1997, 35 (04) : 597 - 605
[43] CAPILLARY PERMEABILITY-INCREASING ENZYME FROM THE VENOM OF AGKISTRODON-CALIGINOSUS (KANKOKU-MAMUSHI) - ACTIVITY DUE TO THE RELEASE OF PEPTIDE MATERIAL FROM A PROTEIN IN BOVINE PLASMA
OHTANI, Y
SUDA, T
TAKAHASHI, H
TOXICON, 1985, 23 (01) : 53 - 61
[44] Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis
Chockalingam, Annapoorani
Zarlenga, Dante S.
Bannerman, Douglas D.
AMERICAN JOURNAL OF VETERINARY RESEARCH, 2007, 68 (11) : 1151 - 1159
[45] EVIDENCE FOR 2 TYPES OF VASCULAR PERMEABILITY-INCREASING MEDIATORS - THE DIRECT ACTION OF HISTAMINE AND BRADYKININ - THE POLYMORPH-DEPENDENT ACTION OF C5A, LEUKOTRIENE B4 AND FORMYL TRIPEPTIDE
WEDMORE, CV
WILLIAMS, TJ
BRITISH JOURNAL OF PHARMACOLOGY, 1981, 73 (01) : P209 - P209
[46] A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis
Chockalingam, Annapoorani
McKinney, Cindy E.
Rinaldi, Manuela
Zarlenga, Dante S.
Bannerman, Douglas D.
VETERINARY MICROBIOLOGY, 2007, 125 (1-2) : 80 - 90
[47] The effect of peri-operative recombinant Bactericidal/Permeability-Increasing protein (RBP121) on circulating interleukin-6, vascular endothelial growth factor (VEGF) and endostatin in patients undergoing major hepatectomy
Wu, F
Boelens, P
Cuesta, M
Hansma, A
Hoekman, K
Meijer, S
van Leeuwen, P
HEPATOLOGY, 2002, 36 (04) : 708A - 708A
[48] THE REGION AROUND RESIDUE-115 OF HUMAN BACTERICIDAL PERMEABILITY-INCREASING PROTEIN IS NOT INVOLVED IN LIPOPOLYSACCHARIDE-BINDING OR BACTERICIDAL ACTIVITY - CHEMICAL SYNTHESIS AND EXPRESSION OF A GENE CODING FOR THE ACTIVE DOMAIN AND CHARACTERIZATION OF RECOMBINANT PROTEINS
QI, SY
LI, Y
OCONNOR, CD
BIOCHEMICAL JOURNAL, 1994, 298 : 711 - 718
[49] Anti-neutrophil cytoplasmic antibodies directed against the bactericidal/permeability-increasing protein (BPI) in pediatric cystic fibrosis patients do not recognize N-terminal regions important for the anti-microbial and lipopolysaccharide-binding activity of BPI
Schultz, H
Csernok, E
Schuster, A
Schmitz, TS
Ernst, M
Gross, WL
PEDIATRIC ALLERGY AND IMMUNOLOGY, 2000, 11 (02) : 64 - 70
[50] Enhancement of neonatal innate defense: Effects of adding an N-terminal recombinant fragment of bactericidal/permeability-increasing protein on growth and tumor necrosis factor-inducing activity of gram-negative bacteria tested in neonatal cord blood ex vivo
Levy, O
Sisson, RB
Kenyon, J
Eichenwald, E
Macone, AB
Goldmann, D
INFECTION AND IMMUNITY, 2000, 68 (09) : 5120 - 5125

← 1 2 3 4 5 →